
Equillium EQ
€ 1.00
1.75%
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Equillium P/B 2011-2026 | EQ
P/B Jährlich Equillium
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.75 | 0.655 | 1.63 | 2.03 | 1.98 | 1.55 | -4.46 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.75 | -4.46 | 1.02 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
1.74 | $ 1.7 | 11.11 % | $ 95.7 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | $ 95.05 | 0.42 % | $ 96.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.6 | -11.64 % | $ 408 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.53 | 0.14 % | $ 8.49 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
Biogen
BIIB
|
1.16 | $ 183.04 | -2.44 % | $ 26.7 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 100.16 | 0.31 % | $ 27.2 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 4.1 | -0.97 % | $ 8.92 B | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 205.63 | 1.3 % | $ 5 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
9.64 | $ 37.6 | 0.25 % | $ 3.88 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
3.36 | $ 22.6 | -0.53 % | $ 2.68 B | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
2.04 | $ 55.0 | 3.28 % | $ 4.44 B | ||
|
CRISPR Therapeutics AG
CRSP
|
1.73 | $ 54.77 | 1.73 % | $ 4.62 B | ||
|
Catalyst Biosciences
CBIO
|
0.428 | $ 10.78 | -0.14 % | $ 710 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-0.0391 | $ 60.85 | -2.66 % | $ 6.81 M | ||
|
DBV Technologies S.A.
DBVT
|
23 | $ 17.69 | 4.0 % | $ 1.72 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Celldex Therapeutics
CLDX
|
0.00176 | $ 25.84 | -5.62 % | $ 1.66 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Cellectis S.A.
CLLS
|
0.531 | $ 4.2 | -4.76 % | $ 116 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Enanta Pharmaceuticals
ENTA
|
0.004 | $ 12.63 | -3.66 % | $ 269 K | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 29.04 | 4.69 % | $ 1.41 B | ||
|
Evogene Ltd.
EVGN
|
0.869 | $ 1.1 | -1.0 % | $ 27.9 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 9.59 | 1.43 % | $ 1.55 B | ||
|
Foghorn Therapeutics
FHTX
|
-5.49 | $ 5.87 | 13.76 % | $ 322 M | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
4.51 | $ 63.42 | -1.77 % | $ 8.48 B | ||
|
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
Amicus Therapeutics
FOLD
|
15 | $ 14.29 | 0.04 % | $ 4.35 B |